Business Description
Beijing Beilu Pharmaceutical Co Ltd
NAICS : 325411
SIC : 2833
ISIN : CNE000001QK9
Share Class Description:
SZSE:300016: Class ACompare
Compare
Traded in other countries / regions
300016.China IPO Date
2010-04-06Description
Beijing Beilu Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of pharmaceutical products. The products of the company are contrasted agent series, psychotropic, and hypoglycemic products which include iopamidol injection, iodixanol injection, and reglinide tablets.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.81 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.52 | |||||
| Debt-to-EBITDA | -69.08 | |||||
| Interest Coverage | 0.92 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 2.73 | |||||
| Beneish M-Score | -2.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -20.1 | |||||
| 3-Year EBITDA Growth Rate | -57.1 | |||||
| 3-Year Book Growth Rate | -1.6 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.49 | |||||
| 9-Day RSI | 47.47 | |||||
| 14-Day RSI | 50.02 | |||||
| 6-1 Month Momentum % | 60.93 | |||||
| 12-1 Month Momentum % | 2.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.71 | |||||
| Quick Ratio | 1.99 | |||||
| Cash Ratio | 1.56 | |||||
| Days Inventory | 199.65 | |||||
| Days Sales Outstanding | 62.93 | |||||
| Days Payable | 93.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.2 | |||||
| Shareholder Yield % | -4.32 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 48 | |||||
| Operating Margin % | 5.42 | |||||
| Net Margin % | -5.08 | |||||
| FCF Margin % | 2.09 | |||||
| ROE % | -2.93 | |||||
| ROA % | -1.68 | |||||
| ROIC % | 2.25 | |||||
| ROC (Joel Greenblatt) % | -1.05 | |||||
| ROCE % | -0.5 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 32.62 | |||||
| PS Ratio | 3.35 | |||||
| PB Ratio | 2.01 | |||||
| Price-to-Tangible-Book | 2.3 | |||||
| Price-to-Free-Cash-Flow | 59.57 | |||||
| Price-to-Operating-Cash-Flow | 20.57 | |||||
| EV-to-EBIT | -281.53 | |||||
| EV-to-EBITDA | -281.53 | |||||
| EV-to-Revenue | 3.64 | |||||
| EV-to-FCF | 174.95 | |||||
| Price-to-Projected-FCF | 1.93 | |||||
| Price-to-Median-PS-Value | 0.52 | |||||
| Earnings Yield (Greenblatt) % | -0.36 | |||||
| FCF Yield % | 0.6 | |||||
| Forward Rate of Return (Yacktman) % | 5.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Beilu Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 970.616 | ||
| EPS (TTM) (Â¥) | -0.103 | ||
| Beta | 1.08 | ||
| Volatility % | 52.84 | ||
| 14-Day RSI | 50.02 | ||
| 14-Day ATR (Â¥) | 0.345034 | ||
| 20-Day SMA (Â¥) | 7.0735 | ||
| 12-1 Month Momentum % | 2.71 | ||
| 52-Week Range (Â¥) | 3.58 - 8.97 | ||
| Shares Outstanding (Mil) | 491.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Beilu Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Beilu Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beijing Beilu Pharmaceutical Co Ltd Frequently Asked Questions
What is Beijing Beilu Pharmaceutical Co Ltd(SZSE:300016)'s stock price today?
The current price of SZSE:300016 is ¥6.85. The 52 week high of SZSE:300016 is ¥8.97 and 52 week low is ¥3.58.
When is next earnings date of Beijing Beilu Pharmaceutical Co Ltd(SZSE:300016)?
The next earnings date of Beijing Beilu Pharmaceutical Co Ltd(SZSE:300016) is .
Does Beijing Beilu Pharmaceutical Co Ltd(SZSE:300016) pay dividends? If so, how much?
Beijing Beilu Pharmaceutical Co Ltd(SZSE:300016) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers